Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003811,
umls-concept:C0027061,
umls-concept:C0028351,
umls-concept:C0030685,
umls-concept:C0205147,
umls-concept:C0205421,
umls-concept:C0232338,
umls-concept:C0391871,
umls-concept:C0457405,
umls-concept:C0475224,
umls-concept:C0680255,
umls-concept:C1280500,
umls-concept:C1283071,
umls-concept:C1963578,
umls-concept:C2587213
|
pubmed:issue |
5
|
pubmed:dateCreated |
1983-12-20
|
pubmed:abstractText |
We studied the effects of yohimbine, and alpha-adrenoceptor blocker with selectivity for the alpha 2-subtype, on myocardial norepinephrine (NE) overflow, regional myocardial blood flow (RMBF), and patterns of epicardial conduction abnormalities during occlusion of the proximal left anterior coronary artery in an open-chest anaesthetised dog model. With a 12-min period of coronary occlusion (n = 9), spontaneous overflow of NE into ischaemic venous effluent was not observed either before or after yohimbine (1 mg/kg i.v.), but the drug significantly potentiated the enhanced NE overflow during supramaximal stimulation of the left stellate ganglion at low (1 Hz) and high (10 Hz) frequency [peak NE 4.3 +/- 0.4 pmol/ml control; 11.8 +/- 5.4 pmol/ml yohimbine (p less than 0.005)] with a delayed return towards prestimulation levels. Myocardial NE overflow on coronary reperfusion was also enhanced. Yohimbine increased arterial epinephrine two- to threefold but did not substantially alter myocardial lactate overflow during coronary occlusion. RMBF was reduced 24 and 36% to ischaemic endocardium and epicardium, respectively (p less than 0.01, compared with control occlusion). This contrasted with a 9 and 6% decrease in flow to the respective nonischaemic areas (p = NS, compared with control occlusion. Spontaneous ventricular fibrillation and the area and magnitude of epicardial conduction abnormalities in the ischaemic myocardium were both increased compared with the control occlusion. Thus, alpha-blockers with selectivity for the alpha 2-adrenoceptor may be detrimental to acutely ischaemic myocardium, presumably through increased local catecholamine release at the nerve terminal.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Lactates,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Yohimbine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0160-2446
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
752-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6195461-Animals,
pubmed-meshheading:6195461-Catecholamines,
pubmed-meshheading:6195461-Coronary Circulation,
pubmed-meshheading:6195461-Dogs,
pubmed-meshheading:6195461-Electrophysiology,
pubmed-meshheading:6195461-Female,
pubmed-meshheading:6195461-Heart,
pubmed-meshheading:6195461-Heart Conduction System,
pubmed-meshheading:6195461-Hemodynamics,
pubmed-meshheading:6195461-Lactates,
pubmed-meshheading:6195461-Male,
pubmed-meshheading:6195461-Myocardium,
pubmed-meshheading:6195461-Norepinephrine,
pubmed-meshheading:6195461-Receptors, Adrenergic, alpha,
pubmed-meshheading:6195461-Yohimbine
|
pubmed:articleTitle |
Alpha-adrenoceptor control of norepinephrine release from acutely ischaemic myocardium: effects of blood flow, arrhythmias, and regional conduction delay.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|